SESSION CODE:
[PL] Plenary Lecture, [SS] Scientific Symposium, [JS] Joint Symposium, [ES] Education Session,
[MDCD] Multi-Disciplinary Case Discussion, [OP] Oral Presentation, [LS] Luncheon Symposium, [SL] Satellite Symposium
Date | Sep.26 (THU) | ||||
Time | Room A | Room B | Room C | Room D | Room E |
08:40-08:50 | |||||
08:50-10:20 | JS 1 ASCO/KSMO |
SS 1 |
ES 1 |
SL 1 (08:50-09:30) |
|
SL 2 (09:40-10:20) |
|||||
10:20-10:30 | Break (10 min.) | ||||
10:30-10:50 | Opening Ceremony | ||||
10:50-11:30 | PL 1 | ||||
11:30-11:40 | Break (10 min.) | ||||
11:40-12:20 | LS 1
|
LS 2
|
LS 3
|
LS 4
|
|
12:20-12:30 | Break (10 min.) | ||||
12:30-14:00 | SS 2 | JS 2 KCSG/KSMO |
ES 2 |
OP1 (12:30-13:30) |
SL 3 (12:30-13:10) |
SL 4 (13:20-14:00) |
|||||
Asia Young Oncologist Forum (13:40-15:40) |
|||||
14:00-14:10 | Break (10 min.) | ||||
14:10-15:40 | JS 3 ESMO/KSMO (1) |
SS 3 | SS 4 | SL 5 (14:10-14:50) |
|
SL 6 (15:00-15:40) |
|||||
15:40-15:50 | Break (10 min.) | ||||
15:50-16:30 | PL 2 | ||||
16:30-17:30 | JS 4 KSR/KSMO |
ES 3 |
MDCD |
SL 7 (16:30-17:10) |
|
Date | Sep.27 (FRI) | ||||
Time | Room A | Room B | Room C | Room D | Room E |
08:40-09:20 | SL 8 |
||||
09:20-10:50 | JS 5 JSMO/KSMO |
JS 6 KSP/KSMO |
SS 5 | OP 2 (09:20-10:20) |
SL 9 (09:20-10:00) |
SL 10 (10:10-10:50) |
|||||
10:50-11:00 | Break (10 min.) | ||||
11:00-11:40 | PL 3 | ||||
11:40-11:50 | Break (10 min.) | ||||
11:50-12:30 | LS 5 |
LS 6 |
LS 7 |
||
12:30-12:40 | Break (10 min.) | ||||
12:40-14:10 | JS 7 ASCO/KSMO (2) |
SS 6 | JS 8 KSSO/KSMO |
SS 7 | SL 11 (12:40-13:20) |
SL 12 (13:30-14:10) |
|||||
14:10-14:20 | Break (10 min.) | ||||
14:20-15:00 | PL 4 | ||||
15:00-15:10 | Break (10 min.) | ||||
15:10-16:40 | JS 9 ESMO/KSMO (2) |
SS 8 |
JS 10 KOSRO/KSMO |
SL 13 (15:10-15:50) |
|
SL 14 (16:00-16:40) |
|||||
16:40-17:00 | Closing Ceremony |
Date | September 26 (THU) | ||||
Time | Room A | Room B | Room C | Room D | Room E |
08:40-08:50 | |||||
08:50-10:20 | JS 1 ASCO/KSMO Oncology innovations in cancer care - Translating new discoveries into treatment for patients with cancer |
SS 1 Navigating current and emerging therapies for breast cancer |
ES 1 ABCs of toxicities management for medical oncologist: Our OLD and NEW foes |
SL 1 (08:50-09:30) |
|
SL 2 (09:40-10:20) |
|||||
10:20-10:30 | Break (10 min.) | ||||
10:30-10:50 | Opening Ceremony | ||||
10:50-11:30 | PL 1 Lessons learned after 50+years of cancer drug development |
||||
11:30-11:40 | Break (10 min.) | ||||
11:40-12:20 | LS 1 | LS 2 | LS 3 | LS 4 | |
12:20-12:30 | Break (10 min.) | ||||
12:30-14:00 | SS 2 Unlocking new immune checkpoint targets : Beyond PD-1/PD-L1 and CTLA4 |
JS 2 KCSG/KSMO Breakthrough of drug development in rare cancers |
ES 2 Early integration of palliative care |
OP1 (12:30-13:30) |
SL 3 (12:30-13:10) |
SL 4 (13:20-14:00) |
|||||
Asia Young Oncologist Forum (13:40-15:40) Asia-Pacific research networking platform for young oncologists: It’s time to collaborate |
|||||
14:00-14:10 | Break (10 min.) | ||||
14:10-15:40 | JS 3 ESMO/KSMO (1) Emerging issues in the treatment of colon and rectal cancers |
SS 3 Oncology drug development: Translating biomarkers into breakthroughs |
SS 4 The forthcoming future of genitourinary cancers |
SL 5 (14:10-14:50) |
|
SL 6 (15:00-15:40) |
|||||
15:40-15:50 | Break (10 min.) | ||||
15:50-16:30 | PL 2 Rapidly expanding treatment options in lung cancer |
||||
16:30-17:30 | JS 4 KSR/KSMO AI application on oncology imaging |
ES 3 Technologies revolutionizing cancer treatment and care |
MDCD Optimization of treatment for BRPC/LAPC |
SL 7 (16:30-17:10) |
|
Date | September 27 (FRI) | ||||
Time | Room A | Room B | Room C | Room D | Room E |
08:40-09:20 | SL 8 | ||||
09:20-10:50 | JS 5 JSMO/KSMO Moving the immune checkpoint inhibitors into the partner of surgery |
JS 6 KSP/KSMO Application of digital pathology in precision medicine: Current and future |
SS 5 Emerging immunologic weapons beyond PD1, CTLA4, TIGIT, and LAG3 in lung cancer |
OP 2 (09:20-10:20) |
SL 9 (09:20-10:00) |
SL 10 (10:10-10:50) |
|||||
10:50-11:00 | Break (10 min.) | ||||
11:00-11:40 | PL 3 Cancer as a complex system: Tumor-Stroma-Immune interactions |
||||
11:40-11:50 | Break (10 min.) | ||||
11:50-12:30 | LS 5 |
LS 6 |
LS 7 |
||
12:30-12:40 | Break (10 min.) | ||||
12:40-14:10 | JS 7 ASCO/KSMO (2) Optimal palliative care for cancer patients |
SS 6 Novel therapeutic approaches for GI cancers |
JS 8 KSSO/KSMO Conversion surgery and optimal timing of systemic therapy for GI cancer |
SS 7 Artificial intelligence-driven optimization drug development process: From target discovery to phase I trial |
SL 11 (12:40-13:20) |
SL 12 (13:30-14:10) |
|||||
14:10-14:20 | Break (10 min.) | ||||
14:20-15:00 | PL 4 Hepatocellular carcinoma: What is the big picture? and are we seeing it? |
||||
15:00-15:10 | Break (10 min.) | ||||
15:10-16:40 | JS 9 ESMO/KSMO (2) New horizon in GI cancer |
SS 8 Emerging ADC treatment across cancer types |
JS 10 KOSRO/KSMO Integration of systemic therapy and radiotherapy |
SL 13 (15:10-15:50) |
|
SL 14 (16:00-16:40) |
|||||
16:40-17:00 | Closing Ceremony |